On October 20, 2010
Basket Case: Eli Lilly Grows Ever More Desperate for New Ideas
The FDA’s rejection of Eli Lilly’s new, once-weekly diabetes drug Bydureon underlines what a basket case the once-proud giant of Indianapolis is turning into.
No tags for this post.
0 Comments